Congratulations to Dr. Paola Cappello one of the founding members of @I-PCC for organizing the 2nd International Electronic Conference on Cancers (IECC 2022), entitled “Tumor Microenvironment Heterogeneity in Cancer Progression: Challenge or Opportunity” https://iecc2022.sciforum.net/ which will be held from 14 to 16 February in virtual mode.
The focus of this conference is the translation of basic science understanding of the tumor microenvironment and its dysregulation in cancer to its therapeutic exploitation. Topics of interest include:
Models to study tumor heterogeneity and clonality, targeted therapies exploiting tumor heterogeneity and components of the microenvironment, strategies to unleash the anti-tumor response and overcome intrinsic tumor resistance to therapies, clinical studies with tumor heterogeneity and tumor microenvironment-targeted therapies. 
During the Conference many of @I-PCC members will talk about their research projects.
Dr. Paola Cappello will talk about “IL17A drives stromal reaction in pancreatic cancer toward the immunosuppression: a chance to re-shape the tumor microenvironment”
Dr. Federica Marchesi will talk about “Macrophages in human cancer: clinical relevance and therapeutic potential”
Dr. Vincenzo Corbo will talk about “Subtype-specific stroma in pancreatic cancer”
Dr. Donatella Delle Cave postdoctoral fellow in Dr. Enza Lonardo’s laboratory will talk about “Unraveling the contribution of L1low cancer cell-derived collagen in chemoresistance and metastasis of pancreatic cancer”
Dr. Riccardo Rizzo researcher in Loretta del Mercato’s laboratory will talk about “3D sensing scaffold for extracellular pH mapping at single cell level: A Pre-Clinical Model to Study Cancer Heterogeneity”
Dr. Stefania Forciniti postdoctoral fellow in Dr. Loretta del Mercato’s laboratory will talk about “Emerging 3D in vitro pancreatic cancer models for tumor heterogeneity studies and personalized therapies”